
The Center Engagement Lead (CEL) is a Senior Manager role reporting to the Commercial Associate Director for Haematology, Benelux. In this role the CEL will identify transplant centres in the Netherlands and Belgium to become Authorized Treatment Centers (ATCs) for Vertex’s gene-editing technology, Vertex’s novel gene editing therapy for severe Sickle Cell Disease (SCD) and Transfusion Dependent Thalassemia (TDT) patients. The CEL coordinates a cross functional Vertex team to contract and onboard ATCs, and through ongoing engagement, ensures that Healthcare Professionals and Patients are well supported throughout the treatment journey, from patient referral to infusion with Vertex’s gene-editing technology and post infusion support.
The role is a commercial, non-promotional role, solely focused on operational and technical aspects of the Vertex’s gene-editing technology treatment process and patient journey (ie operational support, onboarding, technical readiness, training coordination, and process support, not product promotion or demand generation).
The role is Field based in Netherlands but supporting activities throughout Netherlands and Belgium, but will on occasions require travel to other locations internationally for meetings and events.
At Vertex, we embrace continuous learning and encourage employees to stay informed on advances in AI, technology, automation, and industry trends. We seek talent who bring an external perspective, demonstrate curiosity and sound judgment, and thoughtfully adopt new capabilities that improve decision-making, drive innovation, increase efficiency, and help deliver better outcomes for patients.
Field
In this Hybrid-Eligible role, you can choose to be designated as:
Note: The Flex status for this position is subject to Vertex’s Policy on Flex @ Vertex Program and may be changed at any time.
#LI-Hybrid
Vertex is a global biotechnology company that invests in scientific innovation.
Vertex is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, sex, gender identity or expression, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, sexual orientation, marital status, or any characteristic protected under applicable law. Vertex is an E-Verify Employer in the United States. Vertex will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
Any applicant requiring an accommodation in connection with the hiring process and/or to perform the essential functions of the position for which the applicant has applied should make a request to the recruiter or hiring manager, or contact Talent Acquisition at ApplicationAssistance@vrtx.com

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and have made significant advancements in multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continue to progress clinical and research programs in these diseases. We also have a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where we have deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency.
Our global HQ is in Boston, and we have research and development (R&D) sites and commercial offices worldwide.
Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. We have also earned a spot on TIME Most Influential Companies, TIME Best Inventions, and Fast Company Most Innovative Companies lists. Our research and medicines have received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the Prix Galien, the Scrip Award and the Breakthrough Prize awards.
Read our community guidelines: https://www.vrtx.com/vertexs-community-guidelines/